Fresenius Kabi (injectable opioids)(FRE.DE)
HQ DE28% share
pharmaceutical · input
IV Parenteral Nutrition Solutions (TPN Bags)
Sterile multi-chamber bags or compounded IV admixtures providing complete or partial nutritional support (amino acids, glucose, lipid emulsion, electrolytes, vitamins, trace elements) for patients unable to absorb nutrition enterally. Critical for: premature neonates (NICU), ICU patients, oncology patients on mucotoxic chemotherapy, patients with short bowel syndrome or intestinal failure. Market concentration: Fresenius Kabi (Kabiven/Smofkabiven), Baxter (Clinimix), B. Braun (Nutriflex). Chronic shortage risk from lipid emulsion ingredient concentration and sterile fill-finish capacity limits.
0
Source countries
2
Companies
0
Goods affected
0
Claims on record
Who makes it
Supplier companies
2 companies produce iv parenteral nutrition solutions (tpn bags).
CJ BIO (CJ CheilJedang)(097950.KS)
HQ KR12% share
CJ BIO, the bioscience division of CJ CheilJedang (Korea); world's largest single L-lysine producer by company; ~15-20% global lysine market share; operates the world's most efficient large-scale fermentation platform; produces from corn-based feedstock in Korea (HQ), Iowa USA, Shenyang China, Liaocheng China, Malaysia, Indonesia, and Brazil; invented high-yield lysine fermentation strains; also the global #1 in tryptophan and a top-5 threonine producer